Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Halozyme Therapeutics
(RV7.F) Q2 2025
Earnings
RV7.F
May 6
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
0.68
0.85
1.03
1.21
Details
Expected EPS
0.814234842
Actual EPS
0.9785205
Surprise EPS
0.16
Surprise Percent
+20.18%
Description
Halozyme Therapeutics (RV7.F) has reported earnings of 0.9785205 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login